Next Article in Journal
Novel Diagnostic Options without Contrast Media or Radiation: Triggered Angiography Non-Contrast-Enhanced Sequence Magnetic Resonance Imaging in Treating Different Leg Venous Diseases
Previous Article in Journal
Determination of Tear Lipid Film Thickness Based on a Reflected Placido Disk Tear Film Analyzer
Open AccessArticle

MRI Types of Cerebral Small Vessel Disease and Circulating Markers of Vascular Wall Damage

1
Research Center of Neurology, 80 Volokolamskoe shosse, 125367 Moscow, Russia
2
LLC PET-Technology, 58, korpus 2, ulica Zorge, 450054 Ufa, Russia
3
Federal State Budgetary Institution “Federal Center for Cerebrovascular Pathology and Stroke”, 1, stroenie 10, Ostrovityanova, 117342 Moscow, Russia
*
Author to whom correspondence should be addressed.
Diagnostics 2020, 10(6), 354; https://doi.org/10.3390/diagnostics10060354
Received: 7 May 2020 / Revised: 26 May 2020 / Accepted: 27 May 2020 / Published: 29 May 2020
(This article belongs to the Section Medical Imaging)
The evaluation of the clustering of magnetic resonance imaging (MRI) signs into MRI types and their relationship with circulating markers of vascular wall damage were performed in 96 patients with cerebral small vessel disease (cSVD) (31 men and 65 women; mean age, 60.91 ± 6.57 years). The serum concentrations of the tumor necrosis factor-α (TNF-α), transforming growth factor-β1 (TGF-β1), vascular endothelial growth factor-A (VEGF-A), and hypoxia-inducible factor 1-α (HIF-1α) were investigated in 70 patients with Fazekas stages 2 and 3 of white matter hyperintensities (WMH) and 21 age- and sex-matched volunteers with normal brain MRI using ELISA. The cluster analysis excluded two patients from the further analysis due to restrictions in their scanning protocol. MRI signs of 94 patients were distributed into two clusters. In the first group there were 18 patients with Fazekas 3 stage WMH. The second group consisted of 76 patients with WMH of different stages. The uneven distribution of patients between clusters limited the subsequent steps of statistical analysis; therefore, a cluster comparison was performed in patients with Fazekas stage 3 WMH, designated as MRI type 1 and type 2 of Fazekas 3 stage. There were no differences in age, sex, degree of hypertension, or other risk factors. MRI type 1 had significantly more widespread WMH, lacunes in many areas, microbleeds, atrophy, severe cognitive and gait impairments, and was associated with downregulation of VEGF-A compared with MRI type 2. MRI type 2 had more severe deep WMH, lacunes in the white matter, no microbleeds or atrophy, and less severe clinical manifestations and was associated with upregulation of TNF-α compared with MRI type 1. The established differences reflect the pathogenetic heterogeneity of cSVD and explain the variations in the clinical manifestations observed in Fazekas stage 3 of this disease. View Full-Text
Keywords: cerebral small vessel disease; neuroimaging; MRI-types; white matter hyperintensities; vascular endothelial growth factor A; tumor necrosis factor-alpha; cognitive dysfunction cerebral small vessel disease; neuroimaging; MRI-types; white matter hyperintensities; vascular endothelial growth factor A; tumor necrosis factor-alpha; cognitive dysfunction
Show Figures

Figure 1

MDPI and ACS Style

Dobrynina, L.A.; Zabitova, M.R.; Shabalina, A.A.; Kremneva, E.I.; Akhmetzyanov, B.M.; Gadzhieva, Z.S.; Berdalin, A.B.; Kalashnikova, L.A.; Gnedovskaya, E.V.; Krotenkova, M.V. MRI Types of Cerebral Small Vessel Disease and Circulating Markers of Vascular Wall Damage. Diagnostics 2020, 10, 354.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop